MRI scans may spare breast cancer patients from harsh chemo
NCT ID NCT07327021
Summary
This study aims to see if MRI scans can identify which patients with aggressive triple-negative breast cancer can safely skip part of their chemotherapy. All participants start with 12 weeks of chemotherapy plus immunotherapy, then get an MRI scan. Those with a complete response on MRI go straight to surgery, avoiding additional harsh chemotherapy drugs. The goal is to maintain cancer control while reducing treatment side effects for those who respond well early.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TNBC - TRIPLE-NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sheba Medical Center
RECRUITINGTel Litwinsky, Israel
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Tel Aviv Sourasky Medical Center
RECRUITINGTel Aviv, Israel
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.